Pathophysiology of Gait and Posture in Progressive Supranuclear Palsy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-09-28

Study Completion Date

2018-07-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main hypothesis is that the gait and postural deficits in the Caribbean form of PSP may be associated with a dysfunction of the cerebral cortex, as they result from sub-cortical involvement in classical forms. The investigators will characterize the gait and posture with a force platform to collect biomechanical gait parameters, coupled with the kinematic and electromyographic (EMG) study. Then the investigators realize a multimodal imaging study \[structural magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI)\] that allow us to determine if a correlation can be found between the clinical characteristics of postural control and walking on one hand, and morphological changes and structural MRI changes in cortico-subcortical pathways on the other hand. The study of performance on neuropsychological tests, registration of ocular movements and the analysis of functional cortical activity will complete our multimodal approach. A better understanding of these disorders is expected to propose new drug treatment and rehabilitative strategies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of Gesture and Executive Functions in Children With High Intellectual Potential

NCT03128125

High Intellectual Potential Children

COMPLETED NA

Elaboration of a Pre-surgery Mapping Protocol of Primary Motor Cortex, Prior to an Implementation of a Stimulation of Primary Motor Cortex for Patients With Deafferentiation of Brachial Plexus Pain

NCT01104506

Painful Avulsion of Brachial Plexus

TERMINATED NA

Cerebellar rTMS Theta Burst for Postural Instability in Progressive Supranuclear Palsy

NCT04222218

Progressive Supranuclear Palsy Fall Gait, Rigid +1 more

COMPLETED NA

Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy

NCT04468932

Palsy Supranuclear Supranuclear Palsy, Progressive

RECRUITING NA

Interhemispheric Plasticity in Humans

NCT00120666

Healthy

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease (6/100 000 inhabitants) characterized by the association of Parkinson's syndrome, a paralysis of the verticality of the gaze and an alteration early balance and walking with the onset of falls during the first year of evolution of the disease. From a neuropathological point of view, it is characterized by a tauopathy with neurodegeneration within the basal ganglia, cerebellum, and midbrain (which includes the mesencephalic locomotor region-MLR).

In the Caribs this pathology is abnormally frequent (incidence over 3 times higher than expected), and represents 1/3 of the total Parkinsonian syndromes. In these patients, cortical pathology predominates leading to different cognitive deficit relative to patients with the classical form of PSP. Conversely, in PSP patients, imaging data suggest a preferential midbrain-thalamocortical pathway dysfunction. Pathophysiological mechanisms causing gait disturbances and postural control presented by these patients remains however not fully elucidated . In patients with Caribbean PSP, of which the clinical features are specific, gait disorders and falls appear later in the course of the disease (2.5 years on average) suggesting perhaps a different physiopathological mechanism. Consequently weak knowledge of the mechanisms involved, none specific treatment is currently available and the taking in therapeutic charge of these disorders rests essentially on a re-educative approach that remains poorly codified.

In this study, gait and balance disorders will be recorded using a force platform, coupled with kinematic study and EMG in patients with classical form of PSP and Caribbean one, and in controls. The functional and anatomy of brain will be examined using a multimodal brain imaging approach (with DTI. Performance in neuropsychological tests and oculomotor movements will also be measured. A comparative and correlation analyses will be performed to assess the link between gait, balance, oculomotor and cognitive performances and brain anatomy, and the differences between subjects groups. Caribbean PSP patients are recruited from Neurology and Physical Medicine and Rehabilitation of University Hospital of Pointe-à-Pitre and Fort de France, Classical PSP patients are be recruited from the Centre d'Investigation Clinique (CIC) of the Pitié-Salpêtrière hospital, and healthy volunteers from both centers.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Progressive Supranuclear Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Intervention Type OTHER

oculomotor movement recordings

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

gait recordings

Intervention Type OTHER

brain magnetic resonance imaging

Intervention Type OTHER

oculomotor movement recordings

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient :
* Patients who met the clinical criteria for PSP and Gd-PSP
* Walking and standing alone without assistance
* Patient or responsible third party who received information about the study and who signed the informed consent
* French
* Patients over 40 years
* Clinically detectable eye movement anomaly

Witnesses :

* To be affiliated or beneficiary of social security scheme
* French person
* Major subjects, matched for age (± 3 years) and sex, showing no neurological or psychiatric disease or severe progressive disease
* No Indication against MRI

Exclusion Criteria

Patient :

* Patient not affiliated with the social security system
* Cognitive impairment: MMSE ≤ 20; FAB ≤ 12
* psychiatric disorders likely to interfere with exploration; severe postural disorders
* MRI not feasible Witnesses
* Not affiliated or benificiary of social security scheme
* Not a french person
* Somebody showing neurological or psychiatric disease or severe progressive disease

Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes